Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2005-10-18
2005-10-18
Ulm, John D. (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
06956102
ABSTRACT:
Provided herein are nucleic acids encoding human NMDA receptor protein subunits and the proteins encoded thereby. In one aspect of the invention, the nucleic acids encode provides In a preferred embodiment, the invention nucleic acids encode MNDAR1, NMDAR2A, NMDAR2B, NMDAR2C and NMDAR2D subunits of human NMDA receptors. The disclosed nucleic acids are also useful as probes, thus enabling those skilled in the art, to identify and isolate related human receptor subunits. Functional glutamate receptors can be assembled, in accordance with the present invention, from a plurality of one type of NMDA receptor subunit protein (homomeric) or from a mixture of two or more types of subunit proteins (heteromeric). Also provided are methods for using the disclosed receptor subunits to identify and characterize compounds which affect the function of such receptors, e.g., agonists, antagonists, and modulators of glutamate receptor function. Methods for determining whether unknown protein(s) are functional as NMDA receptor subunits are also provided.
REFERENCES:
patent: 4837148 (1989-06-01), Cregg
patent: 4855231 (1989-08-01), Stroman et al.
patent: 4882279 (1989-11-01), Cregg
patent: 4929555 (1990-05-01), Cregg et al.
patent: 5024939 (1991-06-01), Gorman
patent: 5028707 (1991-07-01), Nichols et al.
patent: 5202257 (1993-04-01), Heinemann et al.
patent: 5401629 (1995-03-01), Harpold et al.
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5436128 (1995-07-01), Harpold et al.
patent: 5985586 (1999-11-01), Daggett et al.
patent: 0600278 (1994-06-01), None
patent: 0606734 (1994-07-01), None
patent: 0674003 (1995-09-01), None
patent: 9223769 (1992-11-01), None
patent: 9307026 (1993-04-01), None
patent: 2291647 (1996-01-01), None
patent: 6014783 (1994-01-01), None
patent: PCT9106648 (1991-05-01), None
patent: PCT9313423 (1993-07-01), None
patent: PCT9323536 (1993-11-01), None
patent: PCT9324629 (1993-12-01), None
patent: PCT9325679 (1993-12-01), None
patent: PCT9401094 (1994-01-01), None
patent: PCT9404698 (1994-03-01), None
patent: PCT9406428 (1994-03-01), None
patent: PCT9411501 (1994-05-01), None
patent: PCT9526401 (1995-10-01), None
Abbott, “NMDA receptor cloned”. Trends Pharmacol. Sci., 12:449. 1991.
Abbott, “NMDA receptor subunit cloned”, Trends Pharmacol. Sci., 12:334. 1991.
Abe, et al., “Molecular characterization of a novel metabotropic glutamate receptor mG1aR5 coupled to inositol phosphate Ca2- signal transduction”. J. Biol. Chem. 267: 13361-13368. 1992.
Albin, et al., “Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's Disease”, N. Engl. J. Med., 322(18):1293-1298. 1990.
Anantharam, et al., “Combinatorial RNA splicing alters the surface charge on the NMDA receptor”. FEBS Lett., 305(1):27-30 (1992).
Bahouth, et al., “Immunological approaches for probing receptor structure and function”. Trends Pharmacol. Sci., 12:338-343 (1991).
Barnard, et al., “Will the real NMDA receptor please stand up”, Trands Phamacol. Sci., 13:11-12, 1992.
Beal, “Mechanism of excitotoxicity in neurologic diseases”. Faseb. J., 6:3338-3444. 1992.
Ben-Ari, et al., “Protein kinase C modulation of NMDA currents: an important link for LTP induction”. TrendsNeurosci., 15:333-339. 1992.
Black, et al., “N-methyl-D-aspartate- or glutamate-mediated toxicity in cultured in rat cortical neurons is antagonized by FPI. 15896AR”. J. Neurochem., 65:2170-2177, 1995.
Bottaro, et al., “Identification of the hepatocyte growth factor receptor as the c-met protooncogene product”. Science. 251:802-084, 1991.
Bradford, et al., “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding”, Anal. Biochem., 72:248, 1976.
Bristow, et al., “The glycine NMDA receptor antagonist R-(−)11A-966, blocks activation of the mesolimbic dopaminergic system induced by pheneyelidine and discilpine (MR-801) in rodents”. Br. J. Pharmacol., 108. 1156-1163. 1993.
Choi, et al., “Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage”, Trands Neurosci., 11(10):465-469. (1988).
Choi, et al., “Glutamate neurotixicity and diseases of the nervous system”,Neuron. 1:623-634. 1988.
Ciba-Geigy Unveils Research Agreement with SIBIA of U.S.., The Wall Street Journal. (Sep. 17, 1992).
Coyle, et al., “Oxidative stress. glutamate. and neurodegenerative disorders”. Science. 262:689-695, 1993.
Daggett, et al., “Cloning and functional characterization of three splice variants of the human NMDARI receptor”. Biophys. J., 36(2):447, 1994.
Dascal, “The use of Nenopus ooxytes for the study of ion channels”, CRC Critical Reviews in Biochemistry. 22(4):317-387 (1987).
Donnelly and Pattona. “Single-channel currents from diethylpyrocarbonate-modified NMDA receptors in cultured rat brain cortical neurons”. J. Gen. Physiol., 105:837-859, 1995.
Dernad, et al., “Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C”, Proc. Natl. Acad. Sci. USA. 89:9359-9363, 1992.
Egebjerg, et al., “Intron sequence directs RNA editing of the glutamate receptor subunit GluR2 coding sequnce”, Proc. Natl. Acad. Sci. USA. 91:10270-10274, 1994.
Felder, et al., “A transfected m1 muscarinic acetylcholine receptor stimulates adenylate cyclase via phosphatidylinisitol hydrolysis”, J. Biol. Chem., 264:20356-20363, 1989.
Fisher and Aronson, “Characterization of the cDNA and genomic sequence of a G protein y subunit (y5)”, Mol. Cell. Biol., 12:1585. 1992.
Foldes, et al., “Cloning and sequence analysis of cDNAs encoding human hippocampus N-methyl-D-aspartate receptor subunits: Evidence for alternative splicing”, Gene. 131:293-298 (1993).
Gautam, et al., “A G protein gamma subunit shares homology wtih ras proteins”, Science. 244:971. 1989.
Gautam, et al., “G Protein diversit is increased by associations with a variety of y subunits”, Proc. Natl. Acad. Sci. USA. 87:7973, 1990.
Gereau and Conn, “Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area C A1”, J. Neurosci. 150:6879-3889. 1995.
Greenamyre, et al., “Synaptic localization of striatal NMDA. quisqualate and kainate receptors”, Neurosci. Lett., 101:133-137, 1989.
Grimwood, et al., “Interactions between the glutamate and glycine recognition sites of the N-methyl-D-aspartate receptor from rat brain. as revealed from radioligand binding studies”, J. Neurochem., 60:1729-1738, 1993.
Gubler, et al., “A simple and very efficient method for generating cDNA libraries”, Gene. 25:263-269, 1983.
Gunasekar, et al., “NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: Implication for cell death”, J. Neurochem. 65:2016-2021, 1995.
Gundersen, et al.. “Glutamate and kainate receptors induced by rat brain messenger ENA in Xenopus oocytes”. Proc. R. Soc. London Ser., 221:127, 1984.
Hess, et al., “Cloning, functional expression, and pharmacological characterization of human NMDAR1 NMDAR2 heteromeric receptors”, Biophys. J., 36(2):446, 1994 (abstract and poster).
Hess, et al., “Biophysical properties of human NMDA receptors stably expressed in mammalisn cells”, Soc. Neurosci. Abstr., 21:1-3, 1995.
Hoffman, “NMDA receptor cloned—twice!”, Science, 254:801-802, 1991.
Hollman, et al., “Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor”.Neuron 10:943-954, 1993.
Hollman, et al., “Cloned glutamate receptors”, Annu. Rev. Neurosci
Daggett Lorrie P.
Ellis Steven B.
Liaw Chen Wang
Lu Chin-Chun
Giesser Joanne M.
Kohli Vineet
Merck & Co. , Inc.
Ulm John D.
LandOfFree
Human N-methyl-D-aspartate receptor subunits nucleic acids... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human N-methyl-D-aspartate receptor subunits nucleic acids..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human N-methyl-D-aspartate receptor subunits nucleic acids... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3475648